Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,961,785
+$278,413 QoQ
Shares Held
7,796
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,973
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Concord Wealth Partners holds $18,338,750 across 12 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
19,775 | $5,022,256 | |
| 2 | LLY |
ELI LILLY & Co
|
3,673 | $4,405,506 | |
| 3 | AMGN |
Amgen Inc
|
11,144 | $4,035,465 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
7,796 | $1,961,785 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,943 | $1,206,735 | |
| 6 | PFE |
Pfizer Inc
|
47,796 | $1,150,927 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,770 | $227,445 | |
| 8 | NVS |
Novartis AG
|
1,264 | $198,094 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,961,785 | 7,796 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,683,372 | 7,740 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,688,312 | 7,389 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,696,030 | 7,325 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,440,225 | 7,759 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,606,599 | 7,668 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,238,596 | 29,480 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $5,346,178 | 27,072 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,408,578 | 25,703 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,163,716 | 22,865 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,043,145 | 19,637 | Shares | Sole | 2024-04-30 | |
| 2023-09-30 | $2,052,258 | 13,768 | Shares | Sole | 2024-04-30 | |
| 2023-06-30 | $1,424,096 | 10,570 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $943,470 | 5,920 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $299,624 | 1,854 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $386,390 | 2,879 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $498,842 | 3,257 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $434,454 | 2,680 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $321,168 | 2,372 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $100,858 | 935 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $177,182 | 1,573 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $207,565 | 1,918 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $220,729 | 2,060 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||